Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study compare the efficacy of Astragalus combined with Gemcitabine to Gemcitabine alone as neoadjuvant treatment for pancreatic cancer.
Epistemonikos ID: 1d005998c3cbb132b2921f2bc968ecbd3ca848ad
First added on: May 15, 2024